Satoru Asahi

1.5k total citations
52 papers, 1.3k citations indexed

About

Satoru Asahi is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Satoru Asahi has authored 52 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 22 papers in Oncology and 12 papers in Pharmacology. Recurrent topics in Satoru Asahi's work include Drug Transport and Resistance Mechanisms (18 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Satoru Asahi is often cited by papers focused on Drug Transport and Resistance Mechanisms (18 papers), Pharmacogenetics and Drug Metabolism (12 papers) and Pharmacological Effects and Toxicity Studies (7 papers). Satoru Asahi collaborates with scholars based in Japan, United States and China. Satoru Asahi's co-authors include Tsuyoshi Yokoi, Toshiyuki Takeuchi, Hiroshi Yamazaki, Sumie Yoshitomi, Tomoko Komatsu, Miki Katoh, Noriaki Shimada, Tsutomu Shimada, Miki Nakajima and Junzo Takahashi and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Applied Microbiology and Biotechnology.

In The Last Decade

Satoru Asahi

52 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Satoru Asahi Japan	16	455	449	382	188	180	52	1.3k
Cho‐Ming Loi United States	23	611 1.3×	615 1.4×	691 1.8×	153 0.8×	144 0.8×	44	1.7k
J. Greg Slatter United States	21	540 1.2×	666 1.5×	762 2.0×	166 0.9×	88 0.5×	50	1.9k
Milin Acharya United States	19	224 0.5×	637 1.4×	934 2.4×	162 0.9×	281 1.6×	36	1.9k
David R. Jones United States	19	979 2.2×	765 1.7×	576 1.5×	311 1.7×	111 0.6×	35	2.3k
David B. Buckley United States	17	499 1.1×	397 0.9×	420 1.1×	178 0.9×	47 0.3×	21	1.2k
Gan Zhou China	25	548 1.2×	389 0.9×	712 1.9×	246 1.3×	87 0.5×	85	1.9k
Kari M. Morrissey United States	18	334 0.7×	777 1.7×	512 1.3×	336 1.8×	108 0.6×	25	1.5k
Heidi J. Einolf United States	25	776 1.7×	499 1.1×	538 1.4×	175 0.9×	50 0.3×	39	1.6k
Vijay Upreti United States	20	328 0.7×	491 1.1×	403 1.1×	206 1.1×	75 0.4×	55	1.7k
Ajai K. Chaudhary United States	23	309 0.7×	624 1.4×	781 2.0×	287 1.5×	192 1.1×	27	2.0k

Countries citing papers authored by Satoru Asahi

Since Specialization

Citations

This map shows the geographic impact of Satoru Asahi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoru Asahi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoru Asahi more than expected).

Fields of papers citing papers by Satoru Asahi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoru Asahi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoru Asahi. The network helps show where Satoru Asahi may publish in the future.

Co-authorship network of co-authors of Satoru Asahi

This figure shows the co-authorship network connecting the top 25 collaborators of Satoru Asahi. A scholar is included among the top collaborators of Satoru Asahi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoru Asahi. Satoru Asahi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yoneyama, Tomoki, Sho Sato, Rosa Fradley, et al.. (2020). Mechanistic Multilayer Quantitative Model for Nonlinear Pharmacokinetics, Target Occupancy and Pharmacodynamics (PK/TO/PD) Relationship of D-Amino Acid Oxidase Inhibitor, TAK-831 in Mice. Pharmaceutical Research. 37(8). 164–164. 7 indexed citations

Tagawa, Yoshihiko, et al.. (2019). The Enhancement of Subcutaneous First-Pass Metabolism Causes Nonlinear Pharmacokinetics of TAK-448 after a Single Subcutaneous Administration to Rats. Drug Metabolism and Disposition. 47(9). 1004–1012. 5 indexed citations

Goto, Akihiko, Yoshihiko Tagawa, Sho Sato, et al.. (2017). Influence of body composition on disposition of the highly fat distributed compound as analysed by physiologically based pharmacokinetic (PBPK) modeling and simulation. Biopharmaceutics & Drug Disposition. 38(9). 543–552. 1 indexed citations

Nishihara, Mitsuhiro, et al.. (2017). Long-Term Stability of Cryopreserved Human Hepatocytes: Evaluation of Phase I and II Drug-Metabolizing Enzyme Activities and CYP3A4/5 Induction for More than a Decade. Drug Metabolism and Disposition. 45(7). 734–736. 6 indexed citations

Morohashi, Akio, Kimio Tohyama, Toshiyuki Takeuchi, et al.. (2017). Mechanism for Covalent Binding of MLN3126, an Oral Chemokine C-C Motif Receptor 9 Antagonist, to Serum Albumins. Drug Metabolism and Disposition. 46(3). 204–213. 4 indexed citations

Nishihara, Mitsuhiro, et al.. (2013). UDP-glucuronosyltransferase 2B15 (UGT2B15) Is the Major Enzyme Responsible for Sipoglitazar Glucuronidation in Humans: Retrospective Identification of the UGT Isoform by In Vitro Analysis and the Effect of UGT2B15*2 Mutation. Drug Metabolism and Pharmacokinetics. 28(6). 475–484. 6 indexed citations

Kogame, Akifumi, Yoshihiko Tagawa, Sachio Shibata, et al.. (2013). Pharmacokinetic and Pharmacodynamic Modeling of Hedgehog Inhibitor TAK-441 for the Inhibition of Gli1 messenger RNA Expression and Antitumor Efficacy in Xenografted Tumor Model Mice. Drug Metabolism and Disposition. 41(4). 727–734. 15 indexed citations

Kogame, Akifumi, et al.. (2012). Evaluation of low background liquid scintillation counter for non-clinical ADME studies. Xenobiotica. 43(6). 520–526. 1 indexed citations

Yamaoka, Masuo, Takahito Hara, Takenori Hitaka, et al.. (2012). Orteronel (TAK-700), a novel non-steroidal 17,20-lyase inhibitor: Effects on steroid synthesis in human and monkey adrenal cells and serum steroid levels in cynomolgus monkeys. The Journal of Steroid Biochemistry and Molecular Biology. 129(3-5). 115–128. 98 indexed citations

10.

Takeuchi, Toshiyuki, Akio Morohashi, Hitomi Yamasaki, et al.. (2012). Absorption of TAK-491, a new angiotensin II receptor antagonist, in animals. Xenobiotica. 43(2). 182–192. 9 indexed citations

11.

Takeuchi, Toshiyuki, et al.. (2011). Differences in the Pharmacokinetics of 4-Amino-3-Chlorophenyl Hydrogen Sulfate, a Metabolite of Resatorvid, in Rats and Dogs. Drug Metabolism and Disposition. 40(4). 648–654. 3 indexed citations

12.

Nishihara, Mitsuhiro, et al.. (2011). An Unusual Metabolic Pathway of Sipoglitazar, a Novel Antidiabetic Agent: Cytochrome P450-Catalyzed Oxidation of Sipoglitazar Acyl Glucuronide. Drug Metabolism and Disposition. 40(2). 249–258. 10 indexed citations

13.

Kaku, Tomohiro, Takenori Hitaka, Akio Ojida, et al.. (2011). Discovery of orteronel (TAK-700), a naphthylmethylimidazole derivative, as a highly selective 17,20-lyase inhibitor with potential utility in the treatment of prostate cancer. Bioorganic & Medicinal Chemistry. 19(21). 6383–6399. 103 indexed citations

14.

Yoshitomi, Sumie, et al.. (2010). Advantages of Human Hepatocyte-Derived Transformants Expressing a Series of Human Cytochrome P450 Isoforms for Genotoxicity Examination. Toxicological Sciences. 116(2). 488–497. 27 indexed citations

15.

Yoshitomi, Sumie, et al.. (2009). In vitro micronucleus test in HepG2 transformants expressing a series of human cytochrome P450 isoforms with chemicals requiring metabolic activation. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 677(1-2). 1–7. 23 indexed citations

16.

Terao, Yasuko, Saku Miyamoto, Kazuko Hirai, et al.. (2009). Hypothermia enhances heat-shock protein 70 production in ischemic brains. Neuroreport. 20(8). 745–749. 27 indexed citations

17.

Yamazaki, Hiroshi, Tomoko Komatsu, Katsuhiro Ohyama, et al.. (2002). Roles of NADPH-P450 Reductase and Apo- and Holo-Cytochrome b5 on Xenobiotic Oxidations Catalyzed by 12 Recombinant Human Cytochrome P450s Expressed in Membranes of Escherichia coli. Protein Expression and Purification. 24(3). 329–337. 206 indexed citations

18.

Asahi, Satoru, et al.. (1996). Effects of Homoserine Dehydrogenase Deficiency on Production of Cytidine by Mutants ofBacillus subtilis. Bioscience Biotechnology and Biochemistry. 60(2). 353–354. 12 indexed citations

19.

Asahi, Satoru, et al.. (1995). A 3-Deazauracil-resistant Mutant ofBacillus subtiliswith Increased Production of Cytidine. Bioscience Biotechnology and Biochemistry. 59(5). 915–916. 9 indexed citations

20.

Tani, Yoshiki, Satoru Asahi, & Hideaki Yamada. (1984). Vitamin K_2 (Menaquinone) : Screening of Producing Microorganisms and Production by Flavobacterium meningosepticum :. Journal of Fermentation Technology. 62(4). 321–327. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact